CA2206423C - Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand - Google Patents
Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand Download PDFInfo
- Publication number
- CA2206423C CA2206423C CA002206423A CA2206423A CA2206423C CA 2206423 C CA2206423 C CA 2206423C CA 002206423 A CA002206423 A CA 002206423A CA 2206423 A CA2206423 A CA 2206423A CA 2206423 C CA2206423 C CA 2206423C
- Authority
- CA
- Canada
- Prior art keywords
- monoclonal antibody
- antibody
- ferm
- hybridoma
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Cette invention se rapporte à un agent antithrombotique contenant comme ingrédient actif un anticorps monoclonal qui réagit avec le facteur de von Willebrand humain qui inhibe l'agrégation plaquettaire induite par ristocétine (APIR), l'agrégation plaquettaire induite par bottrocétine (APIB) et l'agrégation plaquettaire induite par le stress (APIS), et qui ne cause pas de saignement, même lorsqu'il est administré en quantité propre à produire l'effet antithrombotique.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6-297070 | 1994-11-30 | ||
| JP29707094 | 1994-11-30 | ||
| PCT/JP1995/002435 WO1996017078A1 (fr) | 1994-11-30 | 1995-11-29 | Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2206423A1 CA2206423A1 (fr) | 1996-06-06 |
| CA2206423C true CA2206423C (fr) | 2006-07-25 |
Family
ID=36707764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002206423A Expired - Fee Related CA2206423C (fr) | 1994-11-30 | 1995-11-29 | Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2206423C (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021258160A1 (fr) * | 2020-06-26 | 2021-12-30 | Monash University | Anticorps anti-vwf et leurs utilisations |
-
1995
- 1995-11-29 CA CA002206423A patent/CA2206423C/fr not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021258160A1 (fr) * | 2020-06-26 | 2021-12-30 | Monash University | Anticorps anti-vwf et leurs utilisations |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2206423A1 (fr) | 1996-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5916805A (en) | Antithrombotic agent and anti-von Willebrand factor monoclonal antibody | |
| JPWO1996017078A1 (ja) | 抗血栓剤及び抗フォンビルブランド因子モノクローナル抗体 | |
| US5284751A (en) | Antibodies that bind to a ligand-induced binding site on GPIIIa | |
| US5506134A (en) | Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex | |
| US5843442A (en) | Blood coagulation protein antagonists and uses therefor | |
| IE76288B1 (en) | Bispecific monoclonal antibodes their production and use | |
| US9988463B2 (en) | Thrombin-binding antibody molecules and uses thereof | |
| US7754215B2 (en) | Antithrombotic therapy with antibodies binding to the A3 domain of von Willebrand factor (VWF) | |
| EP0206533B1 (fr) | Fragment d'anticorps monoclonal inhibant les plaquettes | |
| US5231025A (en) | Anti-platelet monoclonal antibody | |
| HK1007746B (en) | Platelet inhibiting monoclonal antibody fragment | |
| CA2206423C (fr) | Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand | |
| JP2922955B2 (ja) | トロンビン阻害因子に特異的なモノクローナル抗体 | |
| CA2112701C (fr) | Polypeptides des proteines s et leur utilisation | |
| US5296352A (en) | Monoclonal antibodies directed against complexes formed by thrombin and hirudin | |
| JPH04228088A (ja) | 血小板因子4の生物学的作用を阻害するモノクローナル抗体 | |
| JP4318085B2 (ja) | 抗体およびハイブリドーマ、並びにこれらを用いた免疫学的測定法 | |
| JP2938214B2 (ja) | 血小板凝集阻害作用を持つ新規なモノクローナル抗体、およびその断片 | |
| IE913458A1 (en) | Monoclonal antibodies directed against complexes formed by¹thrombin and thrombin inhibitors | |
| JPH04218389A (ja) | 二重特異性抗体および抗体含有薬剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20141201 |